Retour

Fortress Biotech CEO buys $36.7k in preferred stock - Investing.com

News Fortress Biotech

Fortress Biotech CEO Dr. Lindsay A. Rosenwald has increased his stake in the company by purchasing $36.7k worth of Series A Cumulative Perpetual Preferred Stock. This move demonstrates the CEO's confidence in the company's future prospects.

Investing.com • 10/07/2024 à 14:41:16
Fortress Biotech, Inc.
Adresse: 1111 KANE CONCOURSE
Code postal: 33154
Ville: BAY HARBOR ISLANDS
Region: FL
Numéro de telephone: 781-652-4500
Site internet: https://www.fortressbiotech.com
Status: Active
Info de l'entreprise

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Date de référencement2011-11-17
MarchéStocks
LocaleUS
Echange principalXNAS
TypeCS
DeviseUSD
CIK0001429260
Composite figiBBG001J2MFH6
Share Class figiBBG001V0GB64
Market Cap50,213,818 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employés186
Share Class Shares Outstanding20410000
Weighted Shares Outstanding20412121
Round Lot100
Date de mise à jour2024-07-24
Stats
5 derniers jours
24-07
23-07
22-07
19-07
18-07
Dernier
2.485
2.64
2.38
2.134
2.085
Variation
-5.87%
10.83%
11.37%
2.2%
3.22%
Ouverture
2.64
2.382
2.137
2.088
2.02
Au plus haut
2.79
2.86
2.415
2.17
2.16
Au plus base
2.79
2.838
2.411
2.17
2.147
Historique
PériodeVarAu plus hautAu plus bas
1 semaine
23.02%
2.16
2.147
1 mois
45.75%
1.72
1.696
3 mois
42%
1.77
1.65
6 mois
22.41%
2.13
1.63
1 an
-75.64%
10.3485
1.24
3 ans
-94.69%
47.25
1.24
5 ans
-87.91%
20.55
1.24
10 ans
-95.2%
55.8735
1.24
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Assets 263,551,000 180,719,000 150,549,000 UNPUB
Current Assets 202,381,000 127,611,000 97,826,000 UNPUB
Current Liabilities 129,473,000 128,583,000 97,351,000 UNPUB
Equity 19,806,000 -15,943,000 -13,243,000 UNPUB
Equity Attributable To Noncontrolling Interest -17,990,000 -34,452,000 -29,917,000 UNPUB
Equity Attributable To Parent 37,796,000 18,509,000 16,674,000 UNPUB
Liabilities 243,745,000 196,662,000 163,792,000 UNPUB
Liabilities And Equity 263,551,000 180,719,000 150,549,000 UNPUB
Noncurrent Assets 61,170,000 53,108,000 52,723,000 UNPUB
Noncurrent Liabilities 114,272,000 68,079,000 66,441,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -26,033,000 -65,711,000 -14,465,000 UNPUB
Net Cash Flow, Continuing -26,033,000 -65,711,000 -14,465,000 UNPUB
Net Cash Flow From Financing Activities 22,187,000 -30,381,000 -2,685,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 22,187,000 -30,381,000 -2,685,000 UNPUB
Net Cash Flow From Investing Activities -5,000,000 -2,039,000 4,999,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -5,000,000 -2,039,000 4,999,000 UNPUB
Net Cash Flow From Operating Activities -43,220,000 -33,291,000 -16,779,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -43,220,000 -33,291,000 -16,779,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Comprehensive Income/Loss -55,145,000 -59,301,000 -10,724,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -55,145,000 -59,301,000 -10,724,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Basic Earnings Per Share 0 0 -1 UNPUB
Benefits Costs and Expenses 67,574,000 76,687,000 45,335,000 UNPUB
Cost Of Revenue 6,449,000 7,767,000 6,429,000 UNPUB
Costs And Expenses 71,296,000 67,491,000 48,510,000 UNPUB
Diluted Earnings Per Share 0 0 -1 UNPUB
Gross Profit 5,980,000 9,619,000 28,323,000 UNPUB
Income/Loss From Continuing Operations After Tax -55,145,000 -59,301,000 -10,724,000 UNPUB
Income/Loss From Continuing Operations Before Tax -55,145,000 -59,301,000 -10,583,000 UNPUB
Income Tax Expense/Benefit 0 0 141,000 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -55,145,000 -59,301,000 -10,724,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest -33,608,000 -34,525,000 -5,679,000 UNPUB
Net Income/Loss Attributable To Parent -21,537,000 -24,776,000 -5,045,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -21,537,000 -26,784,000 -7,053,000 UNPUB
Operating Expenses 64,847,000 59,724,000 42,081,000 UNPUB
Operating Income/Loss -58,867,000 -50,105,000 -13,758,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 2,008,000 2,008,000 UNPUB
Preferred Stock Dividends And Other Adjustments 0 2,008,000 2,008,000 UNPUB
Revenues 12,429,000 17,386,000 34,752,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-31
Assets 407,930,000 363,955,000 323,561,000 294,301,000
Current Assets 341,186,000 298,991,000 257,994,000 230,432,000
Current Liabilities 103,140,000 104,921,000 106,303,000 127,715,000
Equity 193,578,000 147,702,000 101,352,000 50,025,000
Equity Attributable To Noncontrolling Interest 95,719,000 70,479,000 39,681,000 8,304,000
Equity Attributable To Parent 97,859,000 77,223,000 61,671,000 41,721,000
Liabilities 214,352,000 216,253,000 222,209,000 244,276,000
Liabilities And Equity 407,930,000 363,955,000 323,561,000 294,301,000
Noncurrent Assets 66,744,000 64,964,000 65,567,000 63,869,000
Noncurrent Liabilities 0 0 115,906,000 116,561,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -18,233,000 -38,740,000 -40,420,000 -127,010,000
Net Cash Flow, Continuing -18,233,000 -38,740,000 -40,420,000 -127,010,000
Net Cash Flow From Financing Activities 49,964,000 2,991,000 3,746,000 75,319,000
Net Cash Flow From Financing Activities, Continuing 49,964,000 2,991,000 3,746,000 75,319,000
Net Cash Flow From Investing Activities -21,337,000 -307,000 -893,000 -22,928,000
Net Cash Flow From Investing Activities, Continuing -21,337,000 -307,000 -893,000 -22,928,000
Net Cash Flow From Operating Activities -46,860,000 -41,424,000 -43,273,000 -179,401,000
Net Cash Flow From Operating Activities, Continuing -46,860,000 -41,424,000 -43,273,000 -179,401,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-31
Comprehensive Income/Loss -49,478,000 -53,930,000 -53,060,000 -213,913,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -49,478,000 -53,930,000 -53,060,000 -213,913,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-14 2023-03-31
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses 73,403,000 72,816,000 69,588,000 289,207,000
Cost Of Revenue 8,203,000 7,633,000 7,221,000 30,775,000
Costs And Expenses 71,195,000 69,812,000 67,262,000 279,307,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit 15,722,000 11,253,000 9,307,000 44,968,000
Income/Loss From Continuing Operations After Tax -49,478,000 -53,930,000 -53,060,000 -213,913,000
Income/Loss From Continuing Operations Before Tax -49,478,000 -53,930,000 -53,060,000 -213,464,000
Income Tax Expense/Benefit 0 0 0 449,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -49,478,000 -53,930,000 -53,060,000 -213,913,000
Net Income/Loss Attributable To Noncontrolling Interest -33,718,000 -32,574,000 -30,549,000 -127,338,000
Net Income/Loss Attributable To Parent -15,760,000 -21,356,000 -22,511,000 -86,575,000
Net Income/Loss Available To Common Stockholders, Basic -15,760,000 -21,356,000 -22,511,000 -86,575,000
Operating Expenses 62,992,000 62,179,000 60,041,000 248,532,000
Operating Income/Loss -47,270,000 -50,926,000 -50,734,000 -203,564,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 23,925,000 18,886,000 16,528,000 75,743,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-28
Assets 391,043,000 418,158,000 407,833,000 396,503,000
Current Assets 317,993,000 320,345,000 301,187,000 346,462,000
Current Liabilities 53,820,000 70,602,000 103,213,000 101,042,000
Equity 244,225,000 248,301,000 212,468,000 225,877,000
Equity Attributable To Noncontrolling Interest 138,323,000 140,020,000 119,810,000 117,203,000
Equity Attributable To Parent 105,902,000 108,281,000 92,658,000 108,674,000
Liabilities 146,818,000 169,857,000 195,365,000 170,626,000
Liabilities And Equity 391,043,000 418,158,000 407,833,000 396,503,000
Noncurrent Assets 73,050,000 97,813,000 106,646,000 50,041,000
Noncurrent Liabilities 0 0 92,152,000 69,584,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 56,546,000 -14,905,000 -22,271,000 72,968,000
Net Cash Flow, Continuing 56,546,000 -14,905,000 -22,271,000 72,968,000
Net Cash Flow From Financing Activities 78,692,000 24,395,000 6,966,000 148,994,000
Net Cash Flow From Financing Activities, Continuing 78,692,000 24,395,000 6,966,000 148,994,000
Net Cash Flow From Investing Activities -458,000 -4,840,000 -7,541,000 40,514,000
Net Cash Flow From Investing Activities, Continuing -458,000 -4,840,000 -7,541,000 40,514,000
Net Cash Flow From Operating Activities -21,688,000 -34,460,000 -21,696,000 -116,540,000
Net Cash Flow From Operating Activities, Continuing -21,688,000 -34,460,000 -21,696,000 -116,540,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-28
Comprehensive Income/Loss -26,066,000 -24,391,000 -45,861,000 -164,826,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -26,066,000 -24,391,000 -45,861,000 -164,826,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 37,653,000 42,234,000 66,946,000 233,144,000
Cost Of Revenue 3,908,000 7,484,000 11,167,000 32,084,000
Costs And Expenses 41,604,000 60,700,000 71,008,000 257,332,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 7,679,000 10,359,000 9,918,000 36,707,000
Income/Loss From Continuing Operations After Tax -26,066,000 -24,391,000 -45,861,000 -164,826,000
Income/Loss From Continuing Operations Before Tax -26,066,000 -24,391,000 -45,861,000 -164,353,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 473,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -26,066,000 -24,391,000 -45,861,000 -164,826,000
Net Income/Loss Attributable To Noncontrolling Interest -17,244,000 -20,856,000 -25,080,000 -100,123,000
Net Income/Loss Attributable To Parent -8,822,000 -3,535,000 -20,781,000 -64,703,000
Net Income/Loss Available To Common Stockholders, Basic -8,822,000 -3,535,000 -20,781,000 -64,703,000
Operating Expenses 37,696,000 53,216,000 59,841,000 225,248,000
Operating Income/Loss -30,017,000 -42,857,000 -49,923,000 -188,541,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 11,587,000 17,843,000 21,085,000 68,791,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-10 2020-11-09 2021-03-31
Assets 228,759,000 268,573,000 295,879,000 328,834,000
Current Assets 158,801,000 199,799,000 237,737,000 261,571,000
Current Liabilities 51,732,000 56,969,000 37,281,000 47,959,000
Equity 75,285,000 116,858,000 176,145,000 196,999,000
Equity Attributable To Noncontrolling Interest 38,057,000 56,381,000 79,034,000 96,661,000
Equity Attributable To Parent 37,228,000 60,477,000 97,111,000 100,338,000
Liabilities 153,474,000 151,715,000 119,734,000 131,835,000
Liabilities And Equity 228,759,000 268,573,000 295,879,000 328,834,000
Noncurrent Assets 69,958,000 68,774,000 58,142,000 67,263,000
Noncurrent Liabilities 0 0 82,453,000 83,876,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-10 2020-11-09 2021-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -915,000 47,335,000 20,182,000 81,564,000
Net Cash Flow, Continuing -915,000 47,335,000 20,182,000 81,564,000
Net Cash Flow From Financing Activities 22,753,000 65,810,000 46,832,000 172,410,000
Net Cash Flow From Financing Activities, Continuing 22,753,000 65,810,000 46,832,000 172,410,000
Net Cash Flow From Investing Activities -1,776,000 -1,063,000 -2,758,000 -7,164,000
Net Cash Flow From Investing Activities, Continuing -1,776,000 -1,063,000 -2,758,000 -7,164,000
Net Cash Flow From Operating Activities -21,892,000 -17,412,000 -23,892,000 -83,682,000
Net Cash Flow From Operating Activities, Continuing -21,892,000 -17,412,000 -23,892,000 -83,682,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-10 2020-11-09 2021-03-31
Comprehensive Income/Loss -24,068,000 -28,463,000 -29,964,000 -102,985,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -24,068,000 -28,463,000 -29,964,000 -102,985,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-11 2020-08-10 2020-11-09 2021-03-31
Basic Earnings Per Share 0 UNPUB UNPUB UNPUB
Benefits Costs and Expenses 36,986,000 37,920,000 39,439,000 148,448,000
Cost Of Revenue 3,810,000 3,124,000 3,379,000 14,594,000
Costs And Expenses 34,446,000 34,853,000 32,518,000 139,869,000
Diluted Earnings Per Share 0 UNPUB UNPUB UNPUB
Gross Profit 9,108,000 6,333,000 6,096,000 31,005,000
Income/Loss From Continuing Operations After Tax -24,068,000 -28,463,000 -29,964,000 -102,985,000
Income/Loss From Continuing Operations Before Tax -24,068,000 -28,463,000 -29,964,000 -102,849,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 136,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -24,068,000 -28,463,000 -29,964,000 -102,985,000
Net Income/Loss Attributable To Noncontrolling Interest -11,698,000 -15,149,000 -14,417,000 -56,459,000
Net Income/Loss Attributable To Parent -12,370,000 -13,314,000 -15,547,000 -46,526,000
Net Income/Loss Available To Common Stockholders, Basic -12,370,000 -13,314,000 -15,547,000 -46,526,000
Operating Expenses 30,636,000 31,729,000 29,139,000 125,275,000
Operating Income/Loss -21,528,000 -25,396,000 -23,043,000 -94,270,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 12,918,000 9,457,000 9,475,000 45,599,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-03-16
Assets 200,538,000 227,264,000 221,588,000 226,422,000
Current Assets 136,549,000 163,511,000 166,312,000 156,252,000
Current Liabilities 48,957,000 36,398,000 46,853,000 45,616,000
Equity 50,709,000 89,820,000 75,000,000 72,532,000
Equity Attributable To Noncontrolling Interest 29,892,000 57,946,000 49,205,000 46,317,000
Equity Attributable To Parent 20,817,000 31,874,000 25,795,000 26,215,000
Liabilities 149,829,000 137,444,000 146,588,000 153,890,000
Liabilities And Equity 200,538,000 227,264,000 221,588,000 226,422,000
Noncurrent Assets 63,989,000 63,753,000 55,276,000 70,170,000
Noncurrent Liabilities 0 0 99,735,000 108,274,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 50,936,000 32,963,000 -14,462,000 71,850,000
Net Cash Flow, Continuing 37,847,000 32,963,000 -14,462,000 58,761,000
Net Cash Flow From Financing Activities 52,113,000 61,894,000 5,552,000 146,714,000
Net Cash Flow From Financing Activities, Continuing 52,113,000 61,894,000 5,552,000 146,714,000
Net Cash Flow From Investing Activities 24,148,000 -611,000 -3,750,000 20,097,000
Net Cash Flow From Investing Activities, Continuing 11,059,000 -611,000 -3,750,000 7,008,000
Net Cash Flow From Operating Activities -25,325,000 -28,320,000 -16,264,000 -94,961,000
Net Cash Flow From Operating Activities, Continuing -25,325,000 -28,320,000 -16,264,000 -94,961,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-03-16
Comprehensive Income/Loss -16,255,000 -27,480,000 -24,970,000 -101,660,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -16,255,000 -27,480,000 -24,970,000 -101,660,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-03-16
Basic Earnings Per Share 0 UNPUB UNPUB UNPUB
Benefits Costs and Expenses 22,732,000 36,730,000 34,742,000 138,289,000
Cost Of Revenue 1,884,000 UNPUB 2,702,000 10,532,000
Costs And Expenses 22,732,000 36,730,000 32,312,000 147,448,000
Diluted Earnings Per Share 0 UNPUB UNPUB UNPUB
Gross Profit 4,593,000 UNPUB 7,070,000 26,097,000
Income/Loss From Continuing Operations After Tax -16,255,000 -27,480,000 -24,970,000 -101,660,000
Income/Loss From Continuing Operations Before Tax -16,255,000 -27,480,000 -24,970,000 -101,660,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -16,255,000 -27,480,000 -24,970,000 -101,660,000
Net Income/Loss Attributable To Noncontrolling Interest -17,647,000 -14,382,000 -12,208,000 -61,700,000
Net Income/Loss Attributable To Parent 1,392,000 -13,098,000 -12,762,000 -39,960,000
Net Income/Loss Available To Common Stockholders, Basic 1,392,000 -13,098,000 -12,762,000 -39,960,000
Operating Expenses 39,085,000 34,540,000 29,610,000 136,916,000
Operating Income/Loss -32,608,000 -25,290,000 -22,540,000 -110,819,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 6,477,000 9,250,000 9,772,000 36,629,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-09 2018-11-09 2019-03-18
Assets 265,075,000 236,866,000 224,919,000 140,993,000
Current Assets 200,157,000 171,524,000 159,518,000 111,207,000
Current Liabilities 79,326,000 62,158,000 70,775,000 55,614,000
Equity 107,546,000 96,265,000 84,637,000 19,743,000
Equity Attributable To Noncontrolling Interest 65,895,000 52,332,000 46,864,000 17,891,000
Equity Attributable To Parent 41,651,000 43,933,000 37,773,000 1,852,000
Liabilities 157,529,000 140,601,000 140,282,000 121,250,000
Liabilities And Equity 265,075,000 236,866,000 224,919,000 140,993,000
Noncurrent Assets 64,918,000 65,342,000 65,401,000 29,786,000
Noncurrent Liabilities 78,203,000 78,443,000 69,507,000 65,636,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-09 2018-11-09 2019-03-18
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 10,105,000 -25,632,000 -3,255,000 -29,376,000
Net Cash Flow, Continuing 10,105,000 -25,632,000 -3,255,000 -37,374,000
Net Cash Flow From Financing Activities 39,655,000 4,383,000 9,961,000 50,648,000
Net Cash Flow From Financing Activities, Continuing 39,655,000 4,383,000 9,961,000 50,648,000
Net Cash Flow From Investing Activities -1,975,000 -2,289,000 9,318,000 18,824,000
Net Cash Flow From Investing Activities, Continuing -1,975,000 -2,289,000 9,318,000 9,041,000
Net Cash Flow From Operating Activities -27,575,000 -27,726,000 -22,534,000 -98,848,000
Net Cash Flow From Operating Activities, Continuing -27,575,000 -27,726,000 -22,534,000 -97,063,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-09 2018-11-09 2019-03-18
Comprehensive Income/Loss -3,818,000 -7,506,000 -4,689,000 -141,936,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,818,000 -7,506,000 -4,689,000 -141,936,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-09 2018-11-09 2019-03-18
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 157,682,000
Cost Of Revenue 1,472,000 1,668,000 UNPUB 6,125,000
Costs And Expenses 45,978,000 39,028,000 38,551,000 157,682,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 53,953,000 62,166,000 UNPUB 20,757,000
Income/Loss From Continuing Operations After Tax -1,741,000 -582,000 -7,337,000 -130,800,000
Income/Loss From Continuing Operations Before Tax 5,903,000 -34,278,000 -27,643,000 -130,800,000
Income Tax Expense/Benefit 0 1,438,000 944,000 0
Interest Expense, Operating 2,083,000 2,144,000 2,228,000 UNPUB
Net Income/Loss -38,218,000 -35,716,000 -28,587,000 -141,936,000
Net Income/Loss Attributable To Noncontrolling Interest 17,200,000 14,105,000 11,949,000 -57,789,000
Net Income/Loss Attributable To Parent -21,018,000 -21,611,000 -16,638,000 -84,147,000
Net Income/Loss Available To Common Stockholders, Basic -21,018,000 -21,611,000 -16,638,000 -84,147,000
Operating Expenses 90,911,000 88,431,000 88,582,000 146,879,000
Operating Income/Loss -40,075,000 -32,213,000 -33,378,000 -119,997,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 5,903,000 6,815,000 5,173,000 26,882,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-09 2017-11-09 2018-03-16
Assets 211,911,000 249,846,000 245,091,000 245,950,000
Current Assets 151,807,000 190,180,000 184,087,000 183,181,000
Current Liabilities 52,800,000 53,468,000 68,428,000 67,428,000
Equity 126,317,000 150,616,000 121,265,000 120,502,000
Equity Attributable To Noncontrolling Interest 78,571,000 78,345,000 84,321,000 67,929,000
Equity Attributable To Parent 47,746,000 72,271,000 36,944,000 52,573,000
Liabilities 85,594,000 99,230,000 123,826,000 125,448,000
Liabilities And Equity 211,911,000 249,846,000 245,091,000 245,950,000
Noncurrent Assets 60,104,000 59,666,000 61,004,000 62,769,000
Noncurrent Liabilities 32,794,000 45,762,000 55,398,000 58,020,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-09 2017-11-09 2018-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 45,743,000 10,307,000 -33,808,000 27,148,000
Net Cash Flow, Continuing 45,743,000 10,307,000 -33,808,000 27,148,000
Net Cash Flow From Financing Activities 58,160,000 54,424,000 17,139,000 154,207,000
Net Cash Flow From Financing Activities, Continuing 58,160,000 54,424,000 17,139,000 154,207,000
Net Cash Flow From Investing Activities -942,000 -20,223,000 -24,836,000 -41,629,000
Net Cash Flow From Investing Activities, Continuing -942,000 -20,223,000 -24,836,000 -41,629,000
Net Cash Flow From Operating Activities -11,475,000 -23,894,000 -26,111,000 -85,430,000
Net Cash Flow From Operating Activities, Continuing -11,475,000 -23,894,000 -26,111,000 -85,430,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-09 2017-11-09 2018-03-16
Comprehensive Income/Loss -9,402,000 -11,781,000 -17,925,000 -99,836,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -9,402,000 -11,781,000 -17,925,000 -99,836,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-09 2017-11-09 2018-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 285,907,000
Cost Of Revenue 469,000 878,000 505,000 3,658,000
Costs And Expenses 106,941,000 124,587,000 126,375,000 285,907,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 44,213,000 49,819,000 46,381,000 183,926,000
Income/Loss From Continuing Operations After Tax -9,402,000 -11,781,000 -17,925,000 -99,836,000
Income/Loss From Continuing Operations Before Tax 44,682,000 50,697,000 46,886,000 -98,323,000
Income Tax Expense/Benefit 0 0 0 1,513,000
Interest Expense, Operating 698,000 1,380,000 3,220,000 5,860,000
Net Income/Loss -14,562,000 -22,949,000 -36,307,000 -99,836,000
Net Income/Loss Attributable To Noncontrolling Interest 2,580,000 5,584,000 9,191,000 -32,960,000
Net Income/Loss Attributable To Parent -11,982,000 -17,365,000 -27,116,000 -66,876,000
Net Income/Loss Available To Common Stockholders, Basic -11,982,000 -17,365,000 -27,116,000 -66,876,000
Operating Expenses 62,259,000 73,890,000 79,489,000 288,792,000
Operating Income/Loss -62,259,000 -73,890,000 -79,489,000 -101,208,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 44,682,000 50,697,000 46,886,000 187,584,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-09 2017-03-16
Assets 104,913,000 98,062,000 145,421,000 170,731,000
Current Assets 84,336,000 76,552,000 98,583,000 109,634,000
Current Liabilities 10,837,000 14,337,000 38,593,000 56,565,000
Equity 70,909,000 58,214,000 74,841,000 82,968,000
Equity Attributable To Noncontrolling Interest 26,344,000 22,877,000 38,215,000 44,473,000
Equity Attributable To Parent 44,565,000 35,337,000 36,626,000 38,495,000
Liabilities 34,004,000 39,848,000 70,580,000 87,763,000
Liabilities And Equity 104,913,000 98,062,000 145,421,000 170,731,000
Noncurrent Assets 20,577,000 21,510,000 46,838,000 61,097,000
Noncurrent Liabilities 23,167,000 25,511,000 31,987,000 31,198,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-09 2017-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -16,767,000 -10,079,000 11,201,000 -9,888,000
Net Cash Flow, Continuing -16,767,000 -10,079,000 11,201,000 -9,888,000
Net Cash Flow From Financing Activities -2,427,000 1,521,000 17,858,000 41,985,000
Net Cash Flow From Financing Activities, Continuing -2,427,000 1,521,000 17,858,000 41,985,000
Net Cash Flow From Investing Activities -2,703,000 -4,218,000 2,166,000 -6,060,000
Net Cash Flow From Investing Activities, Continuing -2,703,000 -4,218,000 2,166,000 -6,060,000
Net Cash Flow From Operating Activities -11,637,000 -7,382,000 -8,823,000 -45,813,000
Net Cash Flow From Operating Activities, Continuing -11,637,000 -7,382,000 -8,823,000 -45,813,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-09 2017-03-16
Comprehensive Income/Loss -7,767,000 -8,567,000 -9,006,000 -71,290,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,767,000 -8,567,000 -9,006,000 -71,290,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-10 2016-08-09 2016-11-09 2017-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 0
Cost Of Revenue 0 324,000 41,000 -790,000
Costs And Expenses 16,231,000 19,272,000 18,155,000 82,190,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 660,000 1,906,000 934,000 17,270,000
Income/Loss From Continuing Operations After Tax -7,767,000 -8,567,000 -9,006,000 -71,290,000
Income/Loss From Continuing Operations Before Tax 660,000 2,230,000 975,000 16,480,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB -73,000
Interest Expense, Operating 620,000 529,000 689,000 3,690,000
Net Income/Loss -16,643,000 -16,389,000 -16,956,000 -71,290,000
Net Income/Loss Attributable To Noncontrolling Interest 4,438,000 3,911,000 3,975,000 -16,195,000
Net Income/Loss Attributable To Parent -12,205,000 -12,478,000 -12,981,000 -55,095,000
Net Income/Loss Available To Common Stockholders, Basic -12,205,000 -12,478,000 -12,981,000 -55,095,000
Operating Expenses 15,751,000 17,042,000 17,180,000 82,190,000
Operating Income/Loss -15,571,000 -17,042,000 -17,180,000 -65,710,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 660,000 2,230,000 975,000 16,480,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2015-08-10 2015-11-09 2016-03-15
Assets UNPUB 83,699,000 86,864,000 118,610,000
Current Assets UNPUB 62,034,000 66,610,000 99,779,000
Current Liabilities UNPUB 4,995,000 8,450,000 10,579,000
Equity UNPUB 55,208,000 54,921,000 84,273,000
Equity Attributable To Noncontrolling Interest UNPUB -673,000 1,310,000 27,427,000
Equity Attributable To Parent UNPUB 55,881,000 53,611,000 56,846,000
Liabilities UNPUB 28,491,000 31,943,000 34,337,000
Liabilities And Equity UNPUB 83,699,000 86,864,000 118,610,000
Noncurrent Assets UNPUB 21,665,000 20,254,000 18,831,000
Noncurrent Liabilities UNPUB 23,496,000 23,493,000 23,758,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2015-08-10 2015-11-09 2016-03-15
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB -7,891,000 -15,474,000 48,423,000
Net Cash Flow, Continuing UNPUB -7,891,000 -15,474,000 48,423,000
Net Cash Flow From Financing Activities UNPUB 26,000 11,068,000 60,916,000
Net Cash Flow From Financing Activities, Continuing UNPUB 26,000 11,068,000 60,916,000
Net Cash Flow From Investing Activities UNPUB -49,000 -20,005,000 7,885,000
Net Cash Flow From Investing Activities, Continuing UNPUB -49,000 -20,005,000 7,885,000
Net Cash Flow From Operating Activities UNPUB -7,868,000 -6,537,000 -20,378,000
Net Cash Flow From Operating Activities, Continuing UNPUB -7,868,000 -6,537,000 -20,378,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2015-08-10 2015-11-09 2016-03-15
Comprehensive Income/Loss UNPUB -5,932,000 -16,467,000 -53,883,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -5,932,000 -16,467,000 -53,883,000
Other Comprehensive Income/Loss UNPUB 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2015-08-10 2015-11-09 2016-03-15
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB 19,453,000 0 54,746,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB 6,382,000 18,122,000 54,746,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB -5,932,000 -16,467,000 -53,883,000
Income/Loss From Continuing Operations Before Tax UNPUB -5,932,000 25,000 -53,883,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB 352,000 350,000 1,484,000
Net Income/Loss UNPUB -6,418,000 -19,855,000 -53,883,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 243,000 1,694,000 -5,455,000
Net Income/Loss Attributable To Parent UNPUB -6,175,000 -18,161,000 -48,428,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -6,175,000 -18,161,000 -48,428,000
Operating Expenses UNPUB 7,762,000 18,097,000 51,394,000
Operating Income/Loss UNPUB -7,762,000 -18,097,000 -50,531,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 0 25,000 863,000
Calendrier économique
25 Juillet 2024 (heure UTC) Actuel Précédent Consensus
★★
08:30
United States
Q2
3.100
2.600
08:30
United States
Q2
1.500
08:30
United States
Q2
3.400
★★
08:30
United States
Q2
3.700
2.700
★★★
08:30
United States
Q2
1.400
2.000
★★
08:30
United States
JUN
0.100
0.300
★★
08:30
United States
JUN
-0.600
0.200
08:30
United States
JUL 21
★★
08:30
United States
JUL 21
243000.000
237000.000
08:30
United States
JUL 19
1867000.000
1860000.000
★★
08:30
United States
JUN
-0.100
0.200
08:30
United States
MAY
-0.200
08:30
United States
JUN
0.800
24 Juillet 2024 (heure UTC) Actuel Précédent Consensus
★★
16:05
United States
13:00
United States
JUL
4.121
4.331
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:FBIO240719P00007500 OPASPS Put American 100 7.5 BATO 2024-07-19
O:FBIO240719P00005000 OPASPS Put American 100 5 BATO 2024-07-19
O:FBIO240719P00002500 OPASPS Put American 100 2.5 BATO 2024-07-19
O:FBIO240719C00007500 OCASPS Call American 100 7.5 BATO 2024-07-19
O:FBIO240719C00005000 OCASPS Call American 100 5 BATO 2024-07-19
O:FBIO240719C00002500 OCASPS Call American 100 2.5 BATO 2024-07-19
O:FBIO240621P00007500 OPASPS Put American 100 7.5 BATO 2024-06-21
O:FBIO240621P00005000 OPASPS Put American 100 5 BATO 2024-06-21
O:FBIO240621P00002500 OPASPS Put American 100 2.5 BATO 2024-06-21
O:FBIO240621C00007500 OCASPS Call American 100 7.5 BATO 2024-06-21
O:FBIO240621C00005000 OCASPS Call American 100 5 BATO 2024-06-21
O:FBIO240621C00002500 OCASPS Call American 100 2.5 BATO 2024-06-21
O:FBIO240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:FBIO240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:FBIO240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:FBIO240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:FBIO240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:FBIO240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:FBIO1240419P00007500 OPASPN Put American 6 7.5 BATO 2024-04-19
O:FBIO1240419P00005000 OPASPN Put American 6 5 BATO 2024-04-19
O:FBIO1240419P00002500 OPASPN Put American 6 2.5 BATO 2024-04-19
O:FBIO1240419C00007500 OCASPN Call American 6 7.5 BATO 2024-04-19
O:FBIO1240419C00005000 OCASPN Call American 6 5 BATO 2024-04-19
O:FBIO1240419C00002500 OCASPN Call American 6 2.5 BATO 2024-04-19
O:FBIO240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:FBIO240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:FBIO240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:FBIO240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:FBIO240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:FBIO240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:FBIO240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:FBIO240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:FBIO240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:FBIO240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:FBIO240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:FBIO240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:FBIO240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:FBIO240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:FBIO240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:FBIO240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:FBIO240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:FBIO240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:FBIO240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:FBIO240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:FBIO240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:FBIO240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:FBIO240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:FBIO240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:FBIO1240119P00007500 OPASPN Put American 6 7.5 BATO 2024-01-19
O:FBIO1240119P00005000 OPASPN Put American 6 5 BATO 2024-01-19
O:FBIO1240119P00002500 OPASPN Put American 6 2.5 BATO 2024-01-19
O:FBIO1240119C00007500 OCASPN Call American 6 7.5 BATO 2024-01-19
O:FBIO1240119C00005000 OCASPN Call American 6 5 BATO 2024-01-19
O:FBIO1240119C00002500 OCASPN Call American 6 2.5 BATO 2024-01-19
O:FBIO231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:FBIO231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:FBIO231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:FBIO231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:FBIO231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:FBIO231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:FBIO1231117P00007500 OPASPN Put American 6 7.5 BATO 2023-11-17
O:FBIO1231117P00005000 OPASPN Put American 6 5 BATO 2023-11-17
O:FBIO1231117P00002500 OPASPN Put American 6 2.5 BATO 2023-11-17
O:FBIO1231117C00007500 OCASPN Call American 6 7.5 BATO 2023-11-17
O:FBIO1231117C00005000 OCASPN Call American 6 5 BATO 2023-11-17
O:FBIO1231117C00002500 OCASPN Call American 6 2.5 BATO 2023-11-17
O:FBIO231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:FBIO231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:FBIO231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:FBIO231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:FBIO231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:FBIO231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:FBIO1231020P00007500 OPASPN Put American 6 7.5 BATO 2023-10-20
O:FBIO1231020P00005000 OPASPN Put American 6 5 BATO 2023-10-20
O:FBIO1231020P00002500 OPASPN Put American 6 2.5 BATO 2023-10-20
O:FBIO1231020C00007500 OCASPN Call American 6 7.5 BATO 2023-10-20
O:FBIO1231020C00005000 OCASPN Call American 6 5 BATO 2023-10-20
O:FBIO1231020C00002500 OCASPN Call American 6 2.5 BATO 2023-10-20
O:FBIO231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:FBIO231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:FBIO231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:FBIO231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:FBIO231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:FBIO231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:FBIO230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:FBIO230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:FBIO230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:FBIO230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:FBIO230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:FBIO230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:FBIO230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:FBIO230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:FBIO230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:FBIO230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:FBIO230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:FBIO230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
Flux d'actualités
News Fortress Biotech
Fortress Biotech CEO Dr. Lindsay A. Rosenwald has increased his stake in the company by purchasing $36.7k worth of Series A Cumulative Perpetual Preferred Stock. This move demonstrates the CEO's confidence in the company's future prospects.
Investing.com • Il y a 2 semaines
Calendar Calendar of Events
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase on Tuesday, May 21, 2024, at 4:20 p.m. ET.
GlobeNewswire Inc. • Il y a 2 mois
Stocks Earnings Releases and Operating Results
Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as early as 2025
GlobeNewswire Inc. • Il y a 2 mois
Stocks Earnings Releases and Operating Results
Record consolidated net revenue of $84.5 million for full-year 2023
GlobeNewswire Inc. • Il y a 3 mois
Calendar Calendar of Events
MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the 36th Annual ROTH Conference on Monday, March 18, 2024, at 2:00 p.m. PT in Dana Point, California. The Company will also attend one-on-one meetings during the conference.
GlobeNewswire Inc. • Il y a 4 mois
Stocks Financing Agreements
Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first FDA-approved treatment for Menkes disease
GlobeNewswire Inc. • Il y a 4 mois
News Long Ideas
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying The Dow Jones index closed lower by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Fortress Biotech The Trade: Fortress Biotech, Inc. (NASDAQ: FBIO) President, CEO and Chairman MD Lindsay Rosenwald acquired a total of 50,000 shares an average price of $2.38. To acquire these shares, it cost around $118,770. What’s Happening: Fortress Biotech recently announced pricing of an $11 million registered direct offering priced at-the-market under Nasdaq rules. What Fortress Biotech Does: Fortress Biotech Inc is a ...
Benzinga • Il y a 6 mois
Stocks Changes in company's own shares
MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced the closing of its previously announced registered direct offering. The company issued 3,303,305 shares of its common stock and warrants to purchase up to 3,303,305 shares of common stock at a combined offering price of $3.33 per share of common stock and accompanying warrant priced at-the-market under Nasdaq rules. The warrants have an exercise price of $3.21 per share, are immediately exercisable, and will expire five years following the date of issuance.
GlobeNewswire Inc. • Il y a 6 mois
News News
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. The company grew deliveries by over 300% from Q3 to Q4, and total deliveries are approximately 4,700, with the majority being Fisker Ocean One launch edition vehicles priced at $68,999. In 2023, Fisker produced 10,142 Fisker Oceans and delivered approximately 4,700 vehicles. Fisker shares jumped 20.8% to $1.8250 on Friday. Here are some other stocks moving in today's mid-day session. Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares climbed 132.6% to $4.8150. Aditxt, Inc. (NASDAQ: ADTX) shares climbed 73.4% to $8.36. Aditxt recently entered into definitive agreement to acquire Evofem Biosciences, Inc. China Green Agriculture, Inc. (NYSE: CGA) gained 68.3% to $3.1982. On Dec. 27, China Green Agriculture entered into a stock purchase agreement with Zhibiao Pan for the acquisition of all outstanding stock of Lonestar Dream for a total consideration of $49 million. Sentage Holdings Inc. (NASDAQ: SNTG) gained 57% to $2.7802. cbdMD, Inc. (NYSE: YCBD) shares climbed 55.7% to $1.2299 after gaining 11% on Thursday. Jin Medical International Ltd. (NASDAQ: ZJYL) gained 40.8% to $245.00. The company recently received a letter from the Nasdaq indicating that a delisting action has been stayed. SYLA Technologies Co., Ltd. (NASDAQ: SYT) rose 27.5% to $5.60. SYLA Technologies recently increased its FY23 guidance. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose 17.8% to $0.3890. Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split. Future FinTech Group Inc. (NASDAQ: FTFT) gained 14.7% to $2.33. Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 14% to $0.22 after gaining 7% on Thursday. Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:
Benzinga • Il y a 6 mois
Stocks Financing Agreements
MIAMI, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that it has entered into a definitive agreement for the issuance and sale of 3,303,305 shares of its common stock and warrants to purchase up to 3,303,305 shares of common stock at a combined offering price of $3.33 per share of common stock and accompanying warrant priced at-the-market under Nasdaq rules. The warrants have an exercise price of $3.21 per share, are immediately exercisable, and will expire five years following the date of issuance.
GlobeNewswire Inc. • Il y a 6 mois
Voir tous
Actualités liées
Dernières actualités

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT